There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 6089-09-4 | MDL No. : | MFCD00004407 |
Formula : | C5H6O2 | Boiling Point : | - |
Linear Structure Formula : | CHCCH2CH2COOH | InChI Key : | MLBYLEUJXUBIJJ-UHFFFAOYSA-N |
M.W : | 98.10 | Pubchem ID : | 22464 |
Synonyms : |
Propargylacetic acid
|
Num. heavy atoms : | 7 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 26.08 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.69 cm/s |
Log Po/w (iLOGP) : | 1.13 |
Log Po/w (XLOGP3) : | 0.3 |
Log Po/w (WLOGP) : | 0.56 |
Log Po/w (MLOGP) : | 0.79 |
Log Po/w (SILICOS-IT) : | 0.35 |
Consensus Log Po/w : | 0.63 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -0.51 |
Solubility : | 30.7 mg/ml ; 0.312 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.65 |
Solubility : | 22.2 mg/ml ; 0.226 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.06 |
Solubility : | 84.7 mg/ml ; 0.863 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Danger | Class: | 8 |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | 3261 |
Hazard Statements: | H314 | Packing Group: | Ⅱ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With Jones reagent In acetone at 0 - 20℃; for 1 h; | 23d (lmL, 10.7 mmol) was dissolved in Acetone and cooled to 0°C. Jones reagent was added dropwise to the solution, under vigorous stirring, until the reaction mixture remained orange. The mixture was allowed to reach r.t., and more Jones reagent wasadded to maintain the orange colour. The reaction mixture was stirred at r.t. for lh, then water was added, and was extracted with Et20 several times, washed with Brine and dried over anhydrous Na2504. The solvent was removed at reduced pressure and the resulting oil purified by flash chromatography on silica gel (Hexane/Et20 8:2). Yield 82percent, colourless oil. 1HNMR (400 MHz CDC13-d): ö 2.61-2.59 (m, 2H), 2.52-2.48 (m, 2H), 1.98-1.95 (m, 1H) ppm. |
82% | With Jones reagent In acetone at 0 - 20℃; for 1 h; | 23d (lmL, 10.7 mmol) was dissolved in Acetone and cooled to 0°C. Jones reagent was added dropwise to the solution, under vigorous stirring, until the reaction mixture remained orange. The mixture was allowed to reach r.t., and more Jones reagent was added to maintain the orange colour. The reaction mixture was stirred at r.t. for 1 h, then water was added, and was extracted with Et20 several times, washed with Brine and dried over anhydrous Na2SO4. The solvent was removed at reduced pressure and the resulting oil purified by flash chromatography on silica gel (Hexane/Et20 8:2). Yield 82percent, colourless oil. 1HNMR (400 MHz CDC13-d): ö 2.61-2.59 (m, 2H), 2.52-2.48 (m, 2H), 1.98-1.95 (m, 1H) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51% | With copper(I) iodide; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide | 4-Pentynoic acid, 5-(2,5-dimethoxy-4-methylphenyl)-, methyl ester (4.2) To 3.88 g. (14.0 mmol) of the aryl iodide 4.1 and 1.88 g methyl pentynoate (16.7 mmol) in 50 mL of dry DMF was added 0.277 g. (1.45 mmol) of cuprous iodide and 0.80 g. (0.69 mmol) of tetrakis (triphenylphosphine palladium (0) (Lancaster). The flask was flushed with argon and sealed with a septum, and 3.6 mL of N,N-diisopropylethylamine was added to the flask. After stirring overnight, TLC showed a trace of unreacted starting material. The solution was evaporated and the residue was purified by flash chromatography (5*40 cm silica) using a gradient of 1:1 hexanes-methylene chloride to 100percent methylene chloride. Evaporation gave a dark brown solid. Despite good NMR purity, a second silica gel column was run using an eluent of 4:1 hexanes-ethyl acetate to eliminate color. Appropriate fractions were collected and evaporated to give 1.88 g (51percent yield) of the desired product 4.2 as an off-white solid: mp=66-67 C; TLC (2:1 hexanes-ethyl acetate) Rf=0.63; 1 H NMR (CDCl3), 6.77 (s, 1H), 6.62 (s, 1H), 3.78 (s, 3H), 3.73 (s, 3H), 3.67 (s, 3H), 2.75 (t, 2H, J=6.3 Hz), 2.63 (t, 2H, J=6.3 Hz), 2.16 (s, 3H). Anal. Calcd for C15 H18 O4: C, 68.69; H: 6.92. Found: C: 68.59; H: 6.53. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | at 0 - 85℃; | Preparation 16; But-3-ynyl-carbamic acid tert-butyl ester; Add triethylamine (3 mL) to a solution of 4-pentynoic acid (1.96 g, 20 mmol) in tert-butanol (6 mL) at O0C and then add diphenyl phosphoryl azide (CAUTION: reaction starts violently a short period after the addition). Heat the reaction mixture at 850C overnight under nitrogen. Concentrate in vacuo and purify the crude mixture by chromatography on silica gel eluting with dichloromethane to obtain the title compound as a white solid (1.81g, 53percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With tetrabutyl-ammonium chloride; triethylamine In acetonitrile at 60℃; for 0.25h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1: 62 % Spectr. 2: 3 % Spectr. | With mercuric triflate; tetramethylurea In [D3]acetonitrile at 20℃; for 0.0166667h; | |
With C37H37BCl2O3P2Pd In chloroform-d1 at 100℃; for 8h; Inert atmosphere; Glovebox; Microwave irradiation; | 2.5 General procedure for the microwave assisted cyclisation of alkynoic acids with palladium and platinum catalysts General procedure: A CDCl3 (0.5mL) solution of alkynoic acid (25mg) was added to a CDCl3 (0.5mL) solution of the desired Pd or Pt catalyst (5mol%). The reaction mixtures were heated under microwave conditions at 100°C for 8h. At regular time intervals, the reaction mixtures were monitored by 1H and 13C{1H} NMR spectroscopy to determine the progress of the reaction. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With dicyclohexyl-carbodiimide In tetrahydrofuran at -10 - 20℃; | 10.10a 4-pentynoic acid (5.0 g, 51 mmol) and N-hydroxy succinimide (5.87 g, 51 mmol) were added to a solution of DCC (12.6 g, 61.2 mmol) in THF (125 ml) at -1O0C. The mixture was then stirred for 1 h at -1O0C then left to stir at room temperature overnight. (A white precipitate was observed after 15 min). Acetic acid (0.63 ml) was then added. The resulting DCU was removed by filtration. The filtrate was then evaporated to give 10a (1O g, 100% crude yield). |
99% | With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; for 2.75h; Inert atmosphere; | |
98% | With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate at 20℃; for 5h; |
97% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 2h; Inert atmosphere; | |
96% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 2h; | |
89% | With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; for 2.75h; | |
87% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; | 2,5-dioxopyrrolidin-1-yl pent-4-ynoate (13) 2 (500 mg, 9.12 mmol) was dissolved in 15 mL of DCM. N-hydroxysuccinimide (1 g, 10.19 mmol), DMAP (1.57 g, 10.28 mmol) and EDC.HCl (2.69 g, 14.05 mmol) were added and the reaction was stirred overnight at rt. The solvent was removed under reduced pressure and the crude product purified by flash chromatography using hexane:EtOAc (3:2). 1.55 g of a white solid were obtained, yield 87%. 1H-NMR (300 MHz, DMSO-d6) δ: 2.90-2.83 (6H, m), 2.60 (2H, dt, Jd=2.4, Jt=7.8 Hz), 2.05 (1H, t, J=2.6 Hz). 13C-NMR (300 MHz, DMSO-d6) δ: 169.11 (2C), 167.18, 81.03, 70.26, 30.46, 25.75 (2C), 14.26. MS (ESI) [M+H3O+]+: observed m/z 214 |
87% | With dmap; 1,2-dichloro-ethane In dichloromethane at 20℃; | |
86% | With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; for 2.66h; | |
85% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; | 1 2.0 g (20 mmol) of 4-pentynoic acid was dissolved in 80 ml CH2Cl2. 2.54 g (22 mmol) of N- hydroxysuccinimide (NHS) was added. Then, l-ethyl-3- (3- dimethylaminopropyl) carbodiimide hydrochloride (EDC) was added (4.22 g, 22 mmol). The reaction was stirred at room temperature overnight. The reaction mixture was concentrated and the pure product was separated by silica gel column (hexane : ethyl acetate = 2:1) . Yield: 85%. 1H NMR (500 Hz, CDCl3) δ 2.88-2.83 (m, 6 H), 2.60 (td, J1 = 2.44 Hz, J2 = 7.81 Hz, 2H), 2.04 (t, J= 2.44 Hz, 1 H) ppm. |
84% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; | 1.c 4-pentynoic acid (1 g, 10 mmol, 1 equiv), was dissolved in DMF (20 mL) in presence of Nhydroxysuccinimide (1.77 g, 15 mmol, 1.5 equiv) and EDCJ (2.93, 15 mmol, 1.5 equiv). Thereaction mixture was stirred overnight at rt, concentrated under reduced pressure and finallypurified by flash column chromatography (EP/AcOEt 3:2 then 1:1) to give the desiredintermediate (mass: 1.67 g, yield: 84 %). 1-(pent-4-ynoyloxy)pyrrolidine-2,5-dione (74 mg,0.38 mmol, 1 equiv) and Cyclo(Arg(Pbf)-Gly-Asp(OtBu)-D-Phe-Lys) (230 mg, 0.38 mmol, 1equiv) were dissolved in DMF. Triethylamine (79 il, 0.57 mmol, 1.5 equiv) was added andthe reaction mixture was stuffed until total conversion of the starting material. The productwas concentrated under reduced pressure, dissolved in MeOH followed by precipitation byslow adding of diethyl ether to afford the pure product (mass : 181 mg, yield: 70 %). JR(film): 3265, 2935, 1635, 1540, 1435, 1370, 1200, 1080, 840, 650, 600 cm-’. HRMS (ESJ):(m/z): calcd for C32H45N908+H: 684.3469, found: 684.3489. [diD25 = -4.8 (c=0.001, MeOH). |
84% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; | 1.c Example 1.c Synthesis of intermediate (19) Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-N6-pent-4-ynoyl-L-lysyl) [0115] 4-pentynoic acid (1 g, 10 mmol, 1 equiv), was dissolved in DMF (20 mL) in presence of N-hydroxysuccinimide (1.77 g, 15 mmol, 1.5 equiv) and EDCI (2.93, 15 mmol, 1.5 equiv). The reaction mixture was stirred overnight at rt, concentrated under reduced pressure and finally purified by flash column chromatography (EP/AcOEt 3:2 then 1:1) to give the desired intermediate (mass: 1.67 g, yield: 84 %). 1-(pent-4-ynoyloxy)pyrrolidine-2,5-dione (74 mg, 0.38 mmol, 1 equiv) and Cyclo(Arg(Pbf)-Gly-Asp(OtBu)-D-Phe-Lys) (230 mg, 0.38 mmol, 1 equiv) were dissolved in DMF. Triethylamine (79 µl, 0.57 mmol, 1.5 equiv) was added and the reaction mixture was stirred until total conversion of the starting material. The product was concentrated under reduced pressure, dissolved in MeOH followed by precipitation by slow adding of diethyl ether to afford the pure product (mass : 181 mg, yield : 70 %). IR (film): 3265, 2935, 1635, 1540, 1435, 1370, 1200, 1080, 840, 650, 600 cm-1. HRMS (ESI): (m/z): calcd for C32H45N9O8+H: 684.3469, found: 684.3489. [α]D25 = -4.8 (c=0.001, MeOH). |
83% | Stage #1: 1-hydroxy-pyrrolidine-2,5-dione; 4-pentynoic acid With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; Inert atmosphere; Stage #2: Inert atmosphere; | |
83% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 16h; | |
83% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 16h; | 1 Preparation of 2, 5-dioxopyrrolidin- 1 -yl pent-4-ynoate Preparation of 2, 5-dioxopyrrolidin- 1 -yl pent-4-ynoate 4-Pentynoic acid (2.00 g, 20.36 mmol) was dissolved in DMF (40 mL) and EDCI (5.84 g, 29.84 mmol, 1 .5 equiv.) and NHS (4.68 g, 40.76 mmol, 2.0 equiv.) were added. The mixture was stirred for 16 hours at RT. After evaporation of DMF the residue was diluted in EtOAc (120 mL) and washed two times with NH4CI (1 M, 120 mL) and two times with saturated NaHC03 (120 mL). The organic layer was dried with Na2S04 and the product was purified with flash column chromatography (EtOAc: PE) to obtain the desired activated ester as a white powder (3.3 g, 83 %). 1H NMR (400 MHz, CDCI3): δ 2.89-2.83 (m, 4H), 2.63-2.59 (m, 4H), 1.55 (bs, 1 H); 13C NMR (100 MHz, CDCI3): δ 168.8, 167.0, 80.8, 70.0, 30.3, 25.5, 14.1. |
80% | With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate at 0 - 23℃; for 20h; | 1.1.1.3 Synthesis of N-hydroxysuccinimide ester (21 ) [00161 ] To a solution of 500 mg (5.096 mmol, 1 .0 eq) 3-Butynic acid and 587 mg (5.096 mmol, 1 .0 eq) N-hydroxysuccinimide in 64 mL of 1 :1 -mixture of dry EtOAc and dry dioxane was added 1 .051 g (5.096 mmol, 1 .0 eq) DCC in one portion at 0°C. The mixture was stirred at 0°C for 5 h and additional 15 h at 23°C, before it was filtered and the filtrate was concentrated under reduced pressure. The residue was recrystallized from CH2CI2/Pentane obtaining 800 mg (4.100 mmol, 80%) of 21 as a white amorphous solid. (0238) [00162] N-hydroxysuccinimide ester (21): 1H-NMR (500 MHz, CDCI3) δ [ppm]: 2.86 (dd, J = 8.2, 6.7 Hz, 2H), 2.82 (s, 4H), 2.60 (ddd, J = 8.6, 6.7, 2.7 Hz, 2H), 2.03 (t, J = 2.7 Hz, 1 H). 13C-NMR (126 MHz, CDCI3) δ [ppm] 169.27, 167.39, 81.23, 70.43, 30.70, 25.97, 14.49. |
78% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 15 - 25℃; for 16h; Inert atmosphere; | 4 2,5-dioxopyrrolidin-l-yl pent-4-ynoate (1) To 4-pentynoic acid (80.0 mg, 0.815 mmol) in CH2CI2 (7 mL) was added EDC.HC1 (234 mg, 1.22 mmol), followed by /V-hydroxysuccinimide (140 mg, 1.22 mmol). The resultant mixture was stirred at RT for 16 h, under argon. The solvent was then removed in vacuo and purification by column chromatography (gradient elution from pet. ether to 50% EtOAc in pet. ether) afforded the target compound as a white solid (124 mg, 0.635 mmol, 78%). (0181) mp 65-67 °C; 1H NMR (600 MHz, CDCl3) d H 2.86 (t, 2H, J= 7.2, OC(O)CH2), 2.81 (br s, (0182) 4H, 2 x NC(O)CH2), 2.59 (td, 2H, 7= 7.5, 2.6, CHCCH2), 2.04 (1H, t, J= 2.7, CH); 13C NMR (150 MHz, CDCl3) d c 169.2 (NC(O)), 167.2 (OC(O)), 81.0 (C), 70.2 (CH), 30.4 (NC(O)CH2), 25.7 (OC(O)CH2), 14.2 (CHCCH2); IR (solid) vmax/cm-1 3262 (m), 2955 (w), 2917 (w), 2849 (w), 1811 (m), 1786 (m), 1723 (s); LRMS (ES+) m/z 196 ([M+H]+, 100), 176 (23), 149 (76), 132 (45), 116 (23); HRMS (ES+) calcd for [C10H9NO4]+ [M+H]+ 196.0610, observed 196.0614. |
72% | With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate Cooling with ice; | |
72% | Stage #1: 4-pentynoic acid With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 0.0833333h; Stage #2: 1-hydroxy-pyrrolidine-2,5-dione In dichloromethane at 20℃; for 3h; | |
72% | Stage #1: 4-pentynoic acid With dicyclohexyl-carbodiimide In dichloromethane for 0.0833333h; Stage #2: 1-hydroxy-pyrrolidine-2,5-dione In dichloromethane at 20℃; for 3h; | 1 Pentynoic NHS-ester To a solution of pentynoic acid (210 mg, 2.14 mmol) in DCM (8ml_) was added N, N’-dicyclohexylcarbodiimide (480 mg, 2.3 mmol). The mixture was stirred for 5 mins and then N-hydroxysuccinimide (260 mg, 2.3 mmol) was added. The reaction was continuously stirred at r.t for 3h. Afterwards, the precipitated dicyclohexylcarbamide was filtered off with Celite and the filter cake was washed with cold DCM (2x1 OmL). The filtrate was collected and DCM was removed in vacuo. The product was redissolved in EtOAc (10 ml_) and cooled in a refrigerator at 0°C for 20 mins. The precipitate was filtered off again with Celite and the filtrate was washed with saturated NaHC03 (2x50 ml_) and brine (2x50 ml_), dried over anhydrous MgS04, filtered and concentrated in vacuo to give crude product as colorless oil. Purification of the residue by silica gel column chromatography (petroleum ether: EtOAc= 2:1 ) yield pentynoic NHS-ester as a white solid (300 mg, 72% yield). 1 H NMR (400 MHz, CDCI3): d 2.90-2.82 (m, 6H, COCH2CH2CO, OCOCH2CH2), 2.62 (ddd, 2H, CH2CCH), 2.05 (t, 1 H, CC H). 13C NMR (101 MHz, CDCI3): d 168.89 (COCH2CH2CO), 167.02 (OCOCH2), 80.84 (CH2CCH), 70.04 (CH2CCH), 30.31 (OCOCH2), 25.57 (COCH2CH2CO), 14.09 (CH2CCH). |
69.9% | With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; for 5.5h; | 3.1.3. Preparation of SCT-Asn-Alkyne First, N-(4-pentynoyloxy)-succinimide was synthesized [41]. 4-Pentynoic acid (392.0 mg,1 eq) and N-hydroxysuccinimide (466.0 mg, 1 eq) were dissolved in dry THF (7 mL) andcooled to 0 C. Next, N’-dicyclohexylcarbodiimide (852.0 mg, 1 eq) dissolved in dry THF(2 mL) was added dropwise. The mixture was stirred for 1.5 h at 0 C, slowly warmedto room temperature, and then stirred for an additional 4 h. The precipitate was filtered,and the solvent was evaporated at a reduced pressure. The residue was dissolved in ethylacetate, washed with saturated NaHCO3 solution and brine, and dried over Na2SO4. Thesolvent was evaporated at a reduced pressure, and the residue dissolved in MeOH wassubject to gel filtration with a Sephadex LH-20 column. The column was eluted with MeOH,and product fractions were combined and concentrated in vacuo to yield pent-4-ynoicacid 1-oxysuccinimidyl ester as a white powder (545.1 mg, yield = 69.9%). EI-MS (m/z):195 [M]+, C9H9NO4. 1H-NMR (600 MHz, CD3OD) 2.87 (t, J = 7.2 Hz, 2H, H-4), 2.83 (s,4H, H-7), 2.58 (td, J = 7.2, 2.7 Hz, 2H, H-3), 2.33 (t, J = 2.7 Hz, 1H, H-1). 13C-NMR (101 MHz,CD3OD) 171.7, 168.9, 82.2, 70.9, 31.2, 26.5, 14.7. |
66.8% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride at 25 - 30℃; for 1h; | Preparation of BCY9297 To a solution of compound 1 (2 g, 20.4 mmol) in DCM (50 ml.) was added EDCI (7.82 g, 40.8 mmol) and compound 2 (2.58 g, 22.43 mmol, 1.1 eq). The mixture was stirred at 25-30 °C for 1 hr. TLC (Eluent: Petroleum ether: Dichloromethane = 0:1 , Color Developing Reagent: Bromocresol green, Rf = 0.44) indicated Reactant 1 was consumed completely and one new spot formed. The reaction was clean according to TLC. The reaction mixture was then concentrated under reduced pressure to give a residue, following by purification through flash silica gel chromatography (ISCO; 40 g SepaFlash Silica Flash Column, Eluent of 0~50% Ethyl acetate/Petroleum ether gradient 40 mL/min) to give compound 3 (2.8 g, 13.63 mmol, 66.8% yield) as a white solid. |
62.33% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1h; | General Procedure for Preparation of Compound 3 To a solution of compound 1 (500 mg, 5.10 mmol, 1.0 eq) in DCM (25 mL) were added compound 2 (645.2 mg, 5.61 mmol, 1.1 eq) and EDCl (1.95 g, 10.19 mmol, 2.0 eq). The mixture was stirred at 20° C. for 1 hr. TLC (PE: DCM=0:1, Rf=0.43, Color Developing Reagent: Bromocresol green) indicated compound 1 was consumed completely and one new spot was formed. The reaction was clean according to TLC. The reaction mixture was concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO2, Petroleum ether/Ethyl acetate=2/1 to 1:1) to give compound 3 (620 mg, 3.18 mmol, 62.33% yield) as a white solid. (0238) 1H NMR: 400 MHz CDCl3 (0239) δ 2.80-2.95 (m, 6H), 2.55-2.70 (m, 2H), 2.05-2.10 (t, 1H) |
61.6% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 1h; | 6.2 Procedure for preparation of compound B2 To a solution of compound 1 (1 g, 10.19 mmol, 1 eq.) in DCM (50 mL) was added EDCI (3.91 g, 20.39 mmol, 2 eq.) and compound 2 (1.29 g, 1 1.21 mmol, 1.1 eq.). The reaction mixture was stirred at 25 °C for 1 h. TLC indicated compound 1 was consumed completely and one new spot was formed. The reaction mixture was directly purified by flash silica gel chromatography (ISCO; 40 g SepaFlash Silica Flash Column, Eluent of 0-50% Ethyl acetate/Petroleum ether gradient 40 mL/min) to give compound 3 (1.29 g, 6.28 umol, 61.6% yield) as a colorless solid. |
61.6% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 1h; | 23.2.1 Procedure for preparation of compound 3 To a solution of compound 1 (1 g, 10.19 mmol, 1 eq.) in DCM (50 mL) was added EDCI (3.91 g, 20.39 mmol, 2 eq.) and compound 2 (1.29 g, 11.21 mmol, 1.1 eq.). The reaction mixture was stirred at 25 °C for 1 h. TLC indicated compound 1 was consumed completely and one new spot was formed. The reaction mixture was directly purified by flash silica gel chromatography (ISCO; 40 g SepaFlash Silica Flash Column, Eluent of 0-50% Ethyl acetate/Petroleum ether gradient 40 mL/min) to give compound 3 (1.29 g, 6.28 umol, 61.6% yield) as a colorless solid. |
57% | With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate at 20℃; for 5h; | |
50% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 72h; | |
40% | Stage #1: 1-hydroxy-pyrrolidine-2,5-dione; 4-pentynoic acid With dmap In dichloromethane for 0.5h; Stage #2: With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 22℃; for 4h; | |
24% | With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | |
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 18 4-ρentynoic acid (2.943 g, 3.0 mmol) was dissolved in CH2Cl2 (25 niL). N- hydroxysuccinimide (3.80 g, 3.3 mmol) and DCC (4.66 g, 3.0 mmol) were added and the solution was stirred overnight at room temperature. The resulting crude NHS ester 7 was used in the following reaction without further purification.[555] mPEG-NH2 with a molecular weight of 5,000 Da (mPEG-NH2, 1 g, Sunbio) was dissolved in THF (50 mL) and the mixture was cooled to 4 0C. NHS ester 7 (400 mg, 0.4 mmol) was added portion-wise with vigorous stirring. The mixture was allowed to stir for 3 hours while warming to room temperature. Water (2 mL) was then added and the solvent was removed under vacuum. To the residue was added CH2Cl2 (50 mL) and the organic layer was separated, dried over anhydrous Na2SO4, and the volume was reduced to approximately 2 mL. This CH2Cl2 solution was added to ether (150 mL) drop-wise. The resulting precipitate was collected and dried in vacuo. | |
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; for 6.08333h; | ||
With dicyclohexyl-carbodiimide | ||
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 18 4-pentynoic acid (2.943 g, 3.0 mmol) was dissolved in CH2Cl2 (25 mL). N-hydroxysuccinimide (3.80 g, 3.3 mmol) and DCC (4.66 g, 3.0 mmol) were added and the solution was stirred overnight at room temperature. The resulting crude NHS ester 7 was used in the following reaction without further purification. | |
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 6 4-pentynoic acid (2.943 g, 3.0 mmol) was dissolved in CH2Cl2 (25 mL). N-hydroxysuccinimide (3.80 g, 3.3 mmol) and DCC (4.66 g, 3.0 mmol) were added and the solution was stirred overnight at room temperature. The resulting crude NHS ester 7 was used in the following reaction without further purification. | |
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h; | ||
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h; | ||
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; | ||
0.83 g | With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate at 0 - 20℃; for 6h; | |
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; for 5.08333h; Inert atmosphere; | ||
With diisopropyl-carbodiimide In dichloromethane at 20℃; Inert atmosphere; | ||
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0℃; for 22h; | ||
1.62 g | With dicyclohexyl-carbodiimide; 4-(dimethylamino)pyridinium tosylate In acetonitrile at 20℃; | 61 Preparation of 4-Pentyn-1-ol, NHS ester Example 61 Preparation of 4-Pentyn-1-ol, NHS ester A solution of 1.02 grams of 4-pentynoic acid and 1.20 grams of N-hydroxysuccinimide in 20 ml of dry acetonitrile was treated with 300 mg of DPTS, followed by 2.8 grams of DCC, and the reaction was stirred at room temperature overnight. The reaction was filtered and concentrated to give a residue, which was subjected to flash column chromatography on silica gel with 30% ethyl acetate in hexane. The product containing fractions were combined and concentrated to give a 1.62 grams of the desired product as a white solid. NMR (CDCl3): δ 2.89 (d of d, 2H, CH2C=O, J=7.9, 6.4 Hz), 2.85 (s, 4H, O=CCH2CH2C=O), 2.62 (app d of d of d, 2H, CHCCH2, J=8.6, 6.9, 2.7 Hz), 2.06 (t, 1H, CH, J=2.7 Hz). |
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 18.1 4-pentynoic acid (2.943 g, 3.0 mmol) was dissolved in CH2C12 (25 mL). N- hydroxysuccinimide (3.80 g, 3.3 mmol) and DCC (4.66 g, 3.0 mmol) were added and thesolution was stirred overnight at room temperature. The resulting crude NHS ester 7 was used in the following reaction without further purification | |
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 4h; Inert atmosphere; | ||
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran; dichloromethane at 0 - 20℃; | Synthesis of 2,5-dioxopyrrolidin-1-yl pent-4-ynoate (S2) To a solution of S1 (2.4 g, 24.5 mmol) and EDCHCl (9.39 g, 49.0 mmol) in THF/CH2Cl2 (1:2,total 246 mL), HOSu (5.63 g, 49.0 mmol) was added at 0 C. After stirring for overnight at room temperature, aqueous NaHCO3 was added at 0 C. The mixture was extracted with EtOAc for threetimes, washed with brine, and dried over Na2SO4, sequentially. After the desiccant was filtered off,the filtrate was concentrated under reduced pressure to give the product S2 as yellow oil. Half of S2was used for the next step without purification and the other half was stored at -30 C until use. | |
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 3.5h; | ||
With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate at 0 - 20℃; for 12h; | 4-Pentynoic acid succinimidyl ester 4-Pentynoic acid succinimidyl ester: A solution of 4-pentynoic acid (0.5 g, 5.1 mmol) and /V-Hydroxysuccinimide (0.59 g, 1 eq) in EtOAc-Dioxane (1 : 1 , 50 mL) was stirred at 0°C and DCC (1.0g, 1 eq) was added allowing the mixture to reach room temperature (rt) and kept at these conditions for 12 h. The DCU formed was filtrated and the filtrate concentrated under vacuum. EtOAc (100 mL) was added and washed with 5% NaHC03 (2x40 mL), water (40 mL) and brine (40 mL). After drying over anhNa2S04 and concentrating it was recrystallized from DCM/Hexane to obtain a white solid that was used in the next step without further purification. 1H-NMR (400 MHz, CDCI3) δ: 2.90 (t, 2H, J 7.0 Hz), 2.86 (s, 4H), 2.64 (td, 2H, J 7.0, 2.7 Hz), 2.07 (t, 1 H, J 2.7 Hz). | |
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 2 4-pentynoic acid succinimidyl ester: Pentynoic acid (0.98 g, 10.0 mmol) and N-Hydroxysuccinimide (1.15 g, 10 mmol) were suspended in 200 mL of dry dichloromethane, and then N,N′ - Dicyclohexylcarbodiimide (2.06 g, 10 mmol) was added. The reaction mixture was stirred at room temperature overnight, and then the white precipitate was filtered off. The filtrate was concentrated to afford the crude product. Pure 4-pentynoic acid succinimidyl ester was obtained as white solid after recrystallization from dichloromethane/diethylether. 111 NMR complies with the reported value. | |
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; Inert atmosphere; | 4-Pentynoic acid NHS ester (17) 4-Pentynoic acid (10 mg, 0.100 mmol, 1 equiv) was dissolved in 2 mL of dry DCM under argonand cooled to 0 °C. EDC·HCl (23 mg, 0.120 mmol, 1.2 equiv) and NHS (14 mg, 0.120 mmol,1.2 equiv) were sequentially added to the solution and the reaction mixture was stirred overnightat room temperature. The mixture was diluted in 20 mL of DCM and the organic phase waswashed with water (3 × 7 mL), dried over MgSO4, filtrated and concentrated under reducedpressure to give the product as a yellowish oil that was used in next step without furthermodifications. | |
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride | ||
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 24 4-pentynoic acid (2.943 g, 3.0 mmol) was dissolvedin CH2C12 (25 mE). N-hydroxysuccinimide (3.80 g, 3.3mmol) and DCC (4.66 g, 3.0 mmol) were added and thesolution was stirred overnight at room temperature. Theresulting crude NHS ester 7 was used in the following reaction without further purification. | |
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 18.1 [646] 4-pentynoic acid (2.943 g, 3.0 mmol) was dissolved in CH2Cl2 (25 niL). N- hydroxysuccinimide (3.80 g, 3.3 mmol) and DCC (4.66 g, 3.0 mmol) were added and the solution was stirred overnight at room temperature. The resulting crude NHS ester 7 was used in the following reaction without further purification.[647] HiPEG-NH2 with a molecular weight of 5,000 Da (mPEG-NH2, 1 g, Sunbio) was dissolved in THF (50 mL) and the mixture was cooled to 4 0C. NHS ester 7 (400 mg, 0.4 mmol) was added portion-wise with vigorous stirring. The mixture was allowed to stir for 3 hours while warming to room temperature. Water (2 mL) was then added and the solvent was removed under vacuum. To the residue was added CH2Cl2 (50 mL) and the organic layer was separated, dried over anhydrous Na2SO4, and the volume was reduced to approximately 2 mL. This CH2Cl2 solution was added to ether (150 mL) drop-wise. The resulting precipitate was collected and dried in vacuo. | |
With dicyclohexyl-carbodiimide In 1,4-dioxane; ethyl acetate at 0 - 20℃; for 12h; | ||
76.4 mg | With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 2h; | 2.2.4. Synthesis of compound 6 4-Pentynoic acid (5.00 g, 51.0 mmol), NHS (6.40 g, 55.6 mmol), andDMAP (1.24 g, 10.1 mmol) were dissolved in 100 mL CH2Cl2 at 0 °Cfollowed by the addition of DCC (12.6 g, 61.2 mmol) in 50 mL CH2Cl2.The reaction mixture was then warmed to room temperature and stirredfor another 2 h. After filtration, the solution was washed with 1 N HCl,saturated NaHCO3 aqueous solution, and brine. The organic phase wasdried over anhydrous Na2SO4, filtered, and concentrated. The crudeproduct was recrystallized in ethyl acetate/hexane to give PA-NHS as a white crystal with a yield of 76.4%. |
With dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 16h; | ||
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With diphenyl phosphoryl azide; triethylamine; at 0 - 85℃; | Preparation 16; But-3-ynyl-carbamic acid tert-butyl ester; Add triethylamine (3 mL) to a solution of 4-pentynoic acid (1.96 g, 20 mmol) in tert-butanol (6 mL) at O0C and then add diphenyl phosphoryl azide (CAUTION: reaction starts violently a short period after the addition). Heat the reaction mixture at 850C overnight under nitrogen. Concentrate in vacuo and purify the crude mixture by chromatography on silica gel eluting with dichloromethane to obtain the title compound as a white solid (1.81g, 53%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With CuI; triethylamine;PtO2; Pd(PPh3)2Cl2; In tetrahydrofuran; ethanol; ethyl acetate; N,N-dimethyl-formamide; | Step D 5-(3-Cyclopropyl-5,6,7,8-tetrahydro[1,8]naphthyridin-2-yl)-pentanoic acid methyl ester (2-7) A mixture of naphthyridine 2-5 (15.8 g, 77.2 mmol), ester 2-6 (prepared from 4-pentynoic acid and methanolic HCl solution, 11.3 g, 100.4 mmol), CuI (0.7 g, 3.9 mmol), 100 mL Et3N and 100 mL DMF was gently degassed with argon for 10 min. Then Pd(PPh3)2Cl2 was added in one portion. The reaction mixture was heated at 53 C. for 20 hr, cooled to room temperature and quenched with 500 mL water and 100 mL NaHCO3 (sat.). The aqueous mixture was extracted three times with ethyl acetate. The combined organic layer was washed with brine and dried over MgSO4. After solvent removal, the residue was purified by silica gel flash chromatography (EtOAc/Hexane=1/4 to 100% EtOAc over 30 min) to afford an oil, which was subsequently dissolved in 150 mL THF and 50 mL EtOH. Et3N (15 mL, 104 mmol) and PtO2 (0.7 g) were added. The mixture was degassed under moderate vacuum and subjected to balloon hydrogenation condition for 6 hrs. It was then filtered and concentrated to provide the desired product 2-7 as an oil. 1H NMR (400 MHz, CDCl3): delta6.80 (s, 1H), 4.75 (s, 1H), 3.62 (s, 3H), 3.36 (m, 2H), 2.76(t, 2H), 2.64 (t, 2H), 2.36 (t, 2H), 1.88 (m, 2H), 1.78 (m, 5H), 0.86 (m, 2H), 0,50 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | Stage #1: 4-pentynoic acid; 1-adamantanol With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 20℃; for 2h; Stage #2: In dichloromethane at 20℃; for 24h; Further stages.; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | Stage #1: 4-pentynoic acid; N-(2-adamantyl)amine With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 20℃; for 2h; Stage #2: In dichloromethane at 20℃; for 24h; Further stages.; | |
72% | With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 15h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine;bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; In N,N-dimethyl-formamide; at 20 - 80℃;Inert atmosphere; Microwave irradiation; | Description for D160; 3-(5-bromo-7-fluoro-1H-indol-2-yl)propanoic acid (D160); To a solution of <strong>[1201149-19-0](4-bromo-2-fluoro-6-iodophenyl)amine</strong> (D159) (2 g), 4-pentynoic acid (0.62 g) and copper(l) iodide (0.60 g) in DMF (4 ml.) stirred under nitrogen at room temperature was added bis(triphenylphosphine)palladium(ll) chloride (0.222 g), then triethylamine (2.2 ml.) was added in a portion. The reaction mixture was stirred at 80 0C in microwave reactor for 2 hrs. The solid in the mixture was filtered, the filtrate was diluted with EtOAc (30 ml_), washed with brine (80 ml.) and water(50 ml_ x 2). The organic layer was dried over anhydrous sodium sulfate. The dried solution was concentrated. The residue was purified by column chromatography to afford 3- (5-bromo-7-fluoro-1 H-indol-2-yl)propanoic acid (D160) (700 mg) as a yellow solid. MS (ES): C11H9BrFNO2 requires 285; found 286.0 (M+H+). deltaH (CDCI3, 400 MHz): 2.75 (2H, t), 3.07 (2H, t), 5.45 (1 H, s), 7.05 (1 H, d), 7.41 (1 H, s). | |
With triethylamine;bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; In N,N-dimethyl-formamide; at 80℃; for 2.0h;Inert atmosphere; | Description for D160; 3-(5-bromo-7-fluoro-1H-indol-2-yl)propanoic acid (D160); To a solution of <strong>[1201149-19-0](4-bromo-2-fluoro-6-iodophenyl)amine</strong> (D159) (2 g), 4-pentynoic acid (0.62 g) and copper(I) iodide (0.60 g) in DMF (4 mL) stirred under nitrogen at room temperature was added bis(triphenylphosphine)palladium(II) chloride (0.222 g), then triethylamine (2.2 mL) was added in a portion. The reaction mixture was stirred at 80 C. in microwave reactor for 2 hrs. The solid in the mixture was filtered, the filtrate was diluted with EtOAc (30 mL), washed with brine (80 mL) and water (50 mL×2). The organic layer was dried over anhydrous sodium sulfate. The dried solution was concentrated. The residue was purified by column chromatography to afford 3-(5-bromo-7-fluoro-1H-indol-2-yl)propanoic acid (D160) (700 mg) as a yellow solid. MS (ES): C11H9BrFNO2 requires 285. found 286.0 (M+H+). deltaH (CDCl3, 400 MHz): 2.75 (2H, t), 3.07 (2H, t), 5.45 (1H, s), 7.05 (1H, d), 7.41 (1H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In dichloromethane; at 0 - 25℃; for 12h; | Intermediate 10 Benzyl N-r2-(pent-4-vnamido) ethyll carbamate Pentynoic acid (0.590 g, 6 mmol) was added to a suspension of Intermediate 9 ( 1.8 g, 9 mmol), EDCI- HCI ( 1.72 g, 9 mmol) and HOBt. H20 ( 1.21 g, 9 mmol) in dry DCM (30 mL) . The resulting mixture was cooled to 0C and TEA ( 1.25 mL, 9 mmol) was added dropwise. The reaction mixture was stirred at 25C for 12h . The DCM solution was washed with NH4CI solution ( 15 mL) and NaHC03 solution (15 mL), the organic phase was filtered through a phase sepa rator and evaporated to dryness to give the title compound as a white solid ( 1.97 g) . The crude product was used in the next step without further purification. JH NMR (400 M Hz, CDCI3) delta ppm 7.40-7.34 (m, 5H), 6.15 (br s, IH), 5.17 (br s, I H), 5.12 (s, 2H), 3.46-3.34 (m, 4H), 2.52 (dt 2H), 2.38 (t, 2H), 2.0 (br s, I H) . UPLC-MS : Rt=0.75; m/z (ES+) : 275 [M + H] + . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | General procedure: A suspension of alkynoic acids 1 (0.6 mmol), amine nucleophiles 2 or 3 (0.5 mmol), andAuPPh3Cl/AgSbF6 (with the amount indicated) in H2O (4.0 mL) was stirred at the temperatureindicated for 20 h. Then the reaction mixture was cooled to room temperature, and CF3COOH(0.5 mmol) was added, and the resulting mixture was stirred for another 4 h at the temperatureindicated. At ambient temperature, saturated Na2CO3 solution (25.0 mL) was added to the reactionmixture. The resulting mixture was then extracted with ethyl acetate (3 15 mL). The combinedorganic layers were washed with brine, and dried over Na2SO4. After filtration and removal of thesolvents in vacuo, the crude product was purified by flash chromatography on silica gel to yield thedesired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | General procedure: A suspension of alkynoic acids 1 (0.6 mmol), amine nucleophiles 2 or 3 (0.5 mmol), andAuPPh3Cl/AgSbF6 (with the amount indicated) in H2O (4.0 mL) was stirred at the temperatureindicated for 20 h. Then the reaction mixture was cooled to room temperature, and CF3COOH(0.5 mmol) was added, and the resulting mixture was stirred for another 4 h at the temperatureindicated. At ambient temperature, saturated Na2CO3 solution (25.0 mL) was added to the reactionmixture. The resulting mixture was then extracted with ethyl acetate (3 15 mL). The combinedorganic layers were washed with brine, and dried over Na2SO4. After filtration and removal of thesolvents in vacuo, the crude product was purified by flash chromatography on silica gel to yield thedesired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 48h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; diisopropyl-carbodiimide; In dichloromethane; at 25℃; for 12h; | In 140 mL of dichloromethane, 2 mmol of <strong>[17364-16-8]1-palmitoyl-sn-glycero-3-phosphocholine</strong> of formula (V) (from Sigma Company, batch 214-097-4, Pentadecyl (-C15H31), R3 is choline and R5 is hydroxy), 10 mmol of 4-pentynoic acid, 15.7 mmol of diisopropylcarbodiimide and 2.9 mmol of 4-dimethylaminopyridine,The esterification condensation reaction was carried out at 25 C for 12 h to obtain the compound represented by the formula (III)1-Palmitoyl-2- [pent-4-ynoyl] -sn-glycero-3-phosphocholine |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 3h; Inert atmosphere; | 1 4.2.1. N-Succinimidyl-4-pentynoate (1) DIPEA (426 μL, 2.45 mmol) and TSTU (0.675 g, 2.24 mmol) were added to a solution of pentynoic acid (0.2 g, 2.04 mmol) in DMF (3.5 mL) under an Ar atmosphere. The reaction mixture was allowed to stir for 3 h at room temperature. NaCl (saturated aqueous solution, 30 mL) and water (10 mL) were added and the aqueous solution was extracted with EtOAc (3x50 mL). The organic layers were combined, washed with 1 M HCl (120 mL) and dried over Na2SO4. The crude product was further purified by flash chromatography on silica gel (CH2Cl2/EtOAc, 1:1) to afford compound 1 as a white solid (0.36 g, 91%). Mp 70 °C; Rf (EtOAc/CH2Cl2, 1:1, v/v) 0.75; 1H NMR (300 MHz, CDCl3) δ 2.0 (t, 1H, J=2.6 Hz), 2.55 (m, 2H), 2.77 (s, 4H), 2.82 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 14.0, 25.5, 30.2, 70.0, 80.9, 167.0, 169.0; m/z (CI/CH4) 195.86 ([M+H]+); Anal. Calcd for C9H9NO4: C, 55.39%; H, 4.65%; N, 7.18%. Found: C, 55.36%; H, 4.75%; N, 7.31%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In N,N-dimethyl-formamide; for 1h; | Synthesis of Compound 19: N-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl)benzyl)pent-4-ynamide To a solution of pentynoic acid (13 mg, 0.13 mmol) in anhydrous DMF, were added triethylamine (35 mg, 0.35 mmol), HBTU (53 mg, 0.14 mmol), and 7d (50 mg, 0.116 mol). The reaction mixture was stirred for 1 hour, followed by removal of the solvent under vacuum. The residue was then dissolved in ethylacetate and washed with water, brine, dried using sodium sulfate and concentrated under vacuum to obtain the residue which was purified using column chromatography (6% MeOH/dichloromethane) to obtain compound 19 (37 mg, 73%). 1H NMR (500 MHz, MeOD) δ 7.96 (dd, J=8.4, 0.8 Hz, 1H), 7.73 (dd, J=8.3, 0.8 Hz, 1H), 7.63 (ddd, J=8.4, 7.3, 1.2 Hz, 1H), 7.36 (ddd, J=8.4, 7.3, 1.2 Hz, 1H), 7.30 (d, J=8.3 Hz, 2H), 7.05 (d, J=8.3 Hz, 2H), 5.92 (s, 2H), 4.35 (s, 2H), 3.02-2.97 (m, 2H), 2.49-2.43 (m, 2H), 2.43-2.38 (m, 2H), 2.23 (t, J=2.6 Hz, 1H), 1.85 (dt, J=21.1, 7.6 Hz, 2H), 1.46 (dd, J=15.0, 7.5 Hz, 2H), 0.95 (t, J=7.4 Hz, 3H). 13C NMR (126 MHz, MeOD) δ 174.12, 159.09, 150.66, 140.32, 137.69, 135.81, 135.32, 131.00, 129.65, 127.12, 126.92, 126.50, 126.47, 126.03, 123.07, 119.94, 118.82, 114.41, 112.00, 83.65, 70.50, 49.96, 43.73, 36.10, 30.48, 27.90, 23.45, 15.82, 14.23. MS (ESI) calculated for C27H29N5O, m/z 439.24. found 440.25 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | Stage #1: 4-pentynoic acid With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl-formamide at 0℃; for 2h; Stage #2: 2-(acetylamino)ethanethiol In N,N-dimethyl-formamide for 2h; | |
39% | Stage #1: 4-pentynoic acid With dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.0833333h; Stage #2: 2-(acetylamino)ethanethiol With dmap In dichloromethane at 0 - 20℃; | |
Stage #1: 4-pentynoic acid With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃; for 0.166667h; Inert atmosphere; Stage #2: 2-(acetylamino)ethanethiol In dichloromethane at 0 - 20℃; for 16h; Inert atmosphere; |
With adenosine monophosphate ligase SfaB from Streptomyces thioluteus; ATP; magnesium chloride; Cleland's reagent In aq. buffer at 30℃; for 6h; Enzymatic reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 16h; | |
67% | With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 16h; | Synthesis of 1-(pent-4-ynoyloxy)pyrrolidine-2,5-dione In a solution of 4-pentynoic acid (1 equiv, 5.09 mmol, 0.5 g) in DMF (10 mL), EDCI (1.5 equiv, 7.64 mmol, 1.46 g) and NHS (2 equiv, 10.19 mmol, 17 g) were added under stirring. The reaction was stirred 16 hr at rt. After evaporation of DMF, the product was diluted in EtOAc (30 mL) and washed twice with NH4Cl and twice with NaHCO3. The organic layers were dried (MgSO4) and the product was purified on FCC (EtOAc:PE 1:1) to obtain the desired activated esteras a white solid (3.43 mmol, 670 mg, 67 %).1H NMR (400 MHz, CDCl3)δ 2.88 (dd, J = 8.2, 6.7 Hz, 2H, CH2-CO), 2.84 (s, 4H, 2×CH2-CO), 2.62 (ddd, J = 9.6, 6.7, 2.6 Hz, 2H, CH2-C), 2.05 (t, 4J = 2.7 Hz, 1H, CH).13C NMR (400 MHz, CDCl3)δ 169.1 (2×CO), 167.1 (CO), 81.0 (CCH), 70.13 (CCH), 30.36 (CH2), 25.65 (2×CH2), 14.14 (CH2).HRMS-ESI:calcd. for C9H9O4Na: 218.0426; found: 218.0429.IR (neat): 3260, 1735, 1365, 1215, 1070, 990, 950, 840 cm-1. |
With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In dichloromethane at 20℃; | 18 Example 18 (0682) HO2C-(CH2)2-C≡CH+NHS+DCC→NHSO-C(O)-(CH2)2-C≡CH(1) mPEG-NH2+NHSO-C(O)-(CH2)2-C≡CH→mPEG-NH-C(O)-(CH2)2-C≡CH(2) (0683) 4-pentynoic acid (2.943 g, 3.0 mmol) was dissolved in CH2Cl2 (25 mL). N-hydroxysuccinimide (3.80 g, 3.3 mmol) and DCC (4.66 g, 3.0 mmol) were added and the solution was stirred overnight at room temperature. The resulting crude NHS ester 7 was used in the following reaction without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In dichloromethane; at 0 - 25℃; for 16h; | Intermediate 5 Benzyl N-r2-(pent-4-vnamido) propyll carbamate Pentynoic acid (0.267 g, 2.72 mmol) was added to a suspension of Z-propandiamine hydrochloride ( 1 g, 4 mmol), EDCI- HCI 767 mg, 4 mmol) a nd HOBt. H20 (540 mg, 4 mmol) in dry DCM (20 ml_) . The resulting mixture was cooled at 0C a nd TEA ( 1.12 ml_, 8 mmol) was added dropwise. The reaction mixture was stirred at 25C for 16h. The DCM solution was washed with NH4CI solution (20 ml_ x 2) and NaHC03 solution, the organic phase was filtered through a phase separator and evaporated to dryness to obta in the title compound as a white solid (800 mg) . The crude product was used in the next step without further purification . JH NMR (400 MHz, CDCI3) delta 7.41-7.31 (m, 5H), 6.20 (br s, 1 H), 5.27 (br s, 1 H), 5.12 (s, 2H), 3.34 (q , 2H), 3.27 (q , 2H), 2.59-2.52 (m, 2H), 2.42 (t, 2H), 2.02 (br s, 1 H) . UPLC-MS Rt=0.76; m/z (ES+) : 289 [M + H] + . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; for 1h; | To a solution of 1-(2-nitrophenyl) ethanol (1) (940 mg, 5.6 mmol) in DCM (12 mL) was added 4-pentynoic acid (500 muL, 5.6 mmol), N,N'-dicyclohexylcarbodiimide (DCC, 2.06 g, 10.0 mmol) and 4-dimethylamiopryidine (240 mg, 2.0 mmol). The whole mixture was stirred at room temperature for 1 h, and was then poured into ethyl acetate (50 mL). The organic layer was washed with 8percent citric acid aq (2 * 50 mL), brine (2 * 50 mL), and dried over Na2SO4. After removal of ethyl acetate, the organic layer was concentrated in vacuo, and the residue was purified by short silica gel column, eluted with petroleum ether:ethyl acetate (10:1) to give 2 as a clear, yellow oil (970 mg, 3.93 mmol, yield 70percent). 1H NMR (400 MHz, CDCl3) delta 7.95 (dd, J = 8, 1 Hz, 1H), 7.66-7.60 (m, 2H), 7.43 (m, 1H), 6.36 (q, J = 6 Hz, 1H), 2.60-2.55 (m, 2H), 2.51-2.46 (m, 2H), 1.95 (t, J = 3 Hz, 1H), 1.65 (d, J = 6 Hz, 3H); 13C NMR (100 MHz, CDCl3) delta 170.71 147.88, 137.91, 133.65, 128.56, 127.38, 124.60, 82.41, 69.32, 68.67, 33.55, 22.14, 14.43. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; for 24h; | [0075] 4-pentynoic acid was treated with t-Boc protected PEG amine (3) to give compound 11 and deprotected using TFA to afford compound 12, followed by activation using NHS to form its activated ester compound 13. The dendrimer was fully functionalized by amidation of a generation 1 dendrimer bearing a cleavable cystamine core (DNT-294, from Dendritic Nanotechnologies, Inc.) to generate compound 14 leaving a terminal alkyne for orthoganol conjugation through a click reaction. Compound 14 was isolated by preparative HPLC. The purity of 14 was confirmed by LC/MS deconvolution and MALDI analysis. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | General procedure: 4-Pentynoic acid (1.38 g, 14.01 mmol, 1 equiv.) was dissolved in DCM (2mL) then added to an ice-cold solution of EDC (4.026 g, 21 mmol, 1.5 equiv.) and HOBt (2.649 g, 19.59 mmol, 1.4 equiv.) in DCM (25mL). A solution of appropriate 2-naphthylamine (21 mmol, 1.5 equiv.) in DCM (20mL) was then added to the reaction mixture and stirred. Triethylamine (2.13 g, 21 mmol, 1.5 equiv.) was added drop-wise over 10 min. then the reaction temperature was allowed to increase gradually to room temperature. The reaction mixture was stirred for 17 h. The reaction mixture was then diluted with 20 ml DCM, washed with water, 5percent aq. HCl, saturated Aq. sodium bicarbonate solution, and brine solution. The organic layer was dried over anh. sodium sulfate, filtered and the solvent was evaporated under reduced pressure. The crude was purified by column chromatography to afford the corresponding N-(naphthalen-2-yl)pent-4-ynamides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a solution of 5-hexynoic acid (3.0 mmol) in dryCH2Cl2 (5 mL) was added EDCI (3.1 mmol) and HOBt(3.1 mmol). The resulting mixture was stirred at rt for 2 h. Then substituted or unsubstituted 2-aminobenzamide (3.0 mmol) wasadded, and the reaction mixture was stirred at rt for 12 h whilebeing monitored by TLC. After the addition of H2O (10 mL) themixture was extracted with ethyl acetate (3 × 20 mL). Theorganic layers were combined and concentrated under vacuumto give the amide intermediate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a solution of 5-hexynoic acid (3.0 mmol) in dryCH2Cl2 (5 mL) was added EDCI (3.1 mmol) and HOBt(3.1 mmol). The resulting mixture was stirred at rt for 2 h. Then substituted or unsubstituted 2-aminobenzamide (3.0 mmol) wasadded, and the reaction mixture was stirred at rt for 12 h whilebeing monitored by TLC. After the addition of H2O (10 mL) themixture was extracted with ethyl acetate (3 × 20 mL). Theorganic layers were combined and concentrated under vacuumto give the amide intermediate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a solution of 5-hexynoic acid (3.0 mmol) in dryCH2Cl2 (5 mL) was added EDCI (3.1 mmol) and HOBt(3.1 mmol). The resulting mixture was stirred at rt for 2 h. Then substituted or unsubstituted 2-aminobenzamide (3.0 mmol) wasadded, and the reaction mixture was stirred at rt for 12 h whilebeing monitored by TLC. After the addition of H2O (10 mL) themixture was extracted with ethyl acetate (3 × 20 mL). Theorganic layers were combined and concentrated under vacuumto give the amide intermediate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a solution of 5-hexynoic acid (3.0 mmol) in dryCH2Cl2 (5 mL) was added EDCI (3.1 mmol) and HOBt(3.1 mmol). The resulting mixture was stirred at rt for 2 h. Then substituted or unsubstituted 2-aminobenzamide (3.0 mmol) wasadded, and the reaction mixture was stirred at rt for 12 h whilebeing monitored by TLC. After the addition of H2O (10 mL) themixture was extracted with ethyl acetate (3 × 20 mL). Theorganic layers were combined and concentrated under vacuumto give the amide intermediate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a solution of 5-hexynoic acid (3.0 mmol) in dryCH2Cl2 (5 mL) was added EDCI (3.1 mmol) and HOBt(3.1 mmol). The resulting mixture was stirred at rt for 2 h. Then substituted or unsubstituted 2-aminobenzamide (3.0 mmol) wasadded, and the reaction mixture was stirred at rt for 12 h whilebeing monitored by TLC. After the addition of H2O (10 mL) themixture was extracted with ethyl acetate (3 × 20 mL). Theorganic layers were combined and concentrated under vacuumto give the amide intermediate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a solution of 5-hexynoic acid (3.0 mmol) in dryCH2Cl2 (5 mL) was added EDCI (3.1 mmol) and HOBt(3.1 mmol). The resulting mixture was stirred at rt for 2 h. Then substituted or unsubstituted 2-aminobenzamide (3.0 mmol) wasadded, and the reaction mixture was stirred at rt for 12 h whilebeing monitored by TLC. After the addition of H2O (10 mL) themixture was extracted with ethyl acetate (3 × 20 mL). Theorganic layers were combined and concentrated under vacuumto give the amide intermediate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With sodium carbonate In methanol at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 18h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; trichlorophosphate at -15 - 60℃; Inert atmosphere; | ||
With pyridine; trichlorophosphate |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; | General procedure: Esterification of <strong>[5957-80-2]carnosol</strong>, carnosic acid and carnosic acid methyl ester was performed using DCC/DMAP and appropriate acid (4-pentynoic acid or 5-hexynoic acid) according to references [22,23]. Briefly, alkynyl acid (1 eq) was dissolved in dry CH2Cl2 at room temperature under constant stirring. Then, DCC (1 eq) was added, followed by a catalytic amount of DMAP and the corresponding terpene (0.5 eq) dissolved in dry CH2Cl2. The reaction was stopped by adding H2O, extracted with CH2Cl2, dried over Na2SO4, concentrated and purified (58%-76% yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; | In a round bottom flask fitted with magnetic stirrer, 4-pentynoic acid (1.5 g, 15.3 mmol) and (S)-1 -(4-fluoro-phenyl)-ethylamine (1 .8 ml, 16.83 mmol) were dissolved in DCM (50 ml) and then treated with Hunig's base (5.4 ml, 30.6 mmol) and HBTU (1 1 .6 g, 30.6 mmol). This mixture was allowed to stir overnight at r.t. Reaction crude was concentrated under reduced pressure and purified by column chromatography with a gradient of EtOAc and cyclohexane, required product eluted with 40% EtOAc. Required product fractions were combined and concentrated under reduced pressure to afford the title compound (3.21 g, 96%).LCMS Method: 1 , RT: 3.78 min, Ml: 220 [M+1] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; | To a solution of pent-4-ynoic acid (0.1 g, 1 .02 mmol) and 3- aminobenzenesulfonamide (0.21 g, 1 .22 mmol) in dry DMF (5.0 ml) was added HBTU (0.46 g, 1 .22 mmol) followed by DIPEA (212 uL, 1 .22 mmol). The reaction mixture was stirred at ambient temperature for 2 h, or until completion. The mixture was diluted with EtOAc (30 mL), washed with H20 (20 mL), brine (20 mL) then the organics dried (MgS04) and concentrated in vacuo. The crude product was purified by column chromatography on silica gel using 100percent hexanes eluant to give the titled compound as a to give the titled compound as a pale-yellow solid (0.2 g, 79percent). 1H NMR (400 MHz, CD3OD) delta = 8.22 (dd, J = 2.2, 1 .7 Hz, 1 H), 7.75 - 7.68 (m, 1 H), 7.65 - 7.58 (m, 1 H), 7.51 - 7.42 (m, 2H), 2.64 - 2.59 (m, 2H), 2.58 - 2.54 (m, 2H), 2.32 - 2.25 (m, 1 H). 13C NMR (101 MHz, CD3OD) 5 = 171 .3, 143.8, 138.9, 129.2, 122.9, 121 .0, 1 17.1 , 82.1 , 69.1 , 35.4, 14.0. |
79% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 2h; | To a solution of pent-4-ynoic acid (0.1 g, 1.02 mmol) and 3-aminobenzenesulfonamide (0.21 g, 1.22 mmol) in dry DMF (5.0 ml) was added HBTU (0.46 g, 1.22 mmol) followed by DIPEA (212 uL, 1.22 mmol). The reaction mixture was stirred at ambient (0282) temperature for 2 h, or until completion. The mixture was diluted with EtOAc (30 mL), washed with H20 (20 mL), brine (20 mL) then the organics dried (MgS04) and concentrated in vacuo. The crude product was purified by column chromatography on silica gel using 100percent hexanes eluant to give the titled compound as a to give the titled compound as a pale-yellow solid (0.2 g, 79percent). NMR (400 MHz, CD3OD) delta = 8.22 (dd, J = 2.2, 1.7 Hz, lH), 7.75 - 7.68 (m, lH), 7.65 - 7-58 (m, lH), 7.51 - 7.42 (m, 2H), 2.64 - 2.59 (m, 2H), 2.58 - 2.54 (m, 2H), 2.32 - 2.25 (m, lH). C NMR (101 MHz, CD3OD) delta = 171.3, 143.8, 138.9, 129.2, 122.9, 121.0, 117.1, 82.1, 69.1, 35.4, 14.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With 4H3N*4H(1+)*CuMo6O18(OH)6(4-); water; oxygen; sodium carbonate at 50℃; for 12h; | |
76 %Chromat. | With [2,2]bipyridinyl; Iron(III) nitrate nonahydrate; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; acetic acid at 25℃; for 24h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; for 12h;Inert atmosphere; Darkness; | 4.2. General procedure for carotenoid pentynoates. The hydroxy carotenoids were dissolved in dry dichloromethane (20 mg/mL). To the stirred solution 4-pentynoic acid (2 equiv), DMAP (2 equiv) and DCC (2 equiv) were added. The mixture was stirred for 12 h under nitrogen atmosphere, in darkness, at room temperature. Some drops of water (~0.5 mL) and 10 min later hexane (0.5 mL/mg carotenol) were added to the reaction mixture, the obtained precipitate was filtered out, the mother liquor wasdried (Na2SO4) and evaporated under reduced pressure. The products were crystallized from methanol/toluene mixture by the addition of some water. The formed crystals were filtered off, dried in vacuum and stored in closed ampoules under argon. 4.2.1. Zeaxanthin dipentynoate (6) Following the general procedure, <strong>[144-68-3]zeaxanthin</strong> (2, 200 mg, 0.35 mmol) was dissolved in dry dichloromethane (10 mL). To the stirred solution 4-pentynoic acid (69 mg, 0.7 mmol), DMAP (85 mg, 0.7 mmol) and DCC (145 mg, 0.7 mmol) were added. The reaction was worked up, after stirring for 12 h, by addition of some drops of water and 10 min later hexane (100 mL). After filtration, drying and evaporation the product was crystallized. Yield: 136 mg (53 %); orange crystals; mp: 138 C; Rf 0.55 (hexane-eacetone, 4:1). IR (KBr, cm-1): 1727 s (nu C=O, ester), 2120 w (nu C?C), 3308 w (nu ?CH). 1H NMR (500 MHz, CDCl3): delta 1.08,1.11 (2s, 12H, 16, 16', 17,17'-Me), 1.57-1.61 (m, 2H, H-2ax, H-2'ax), 1.72 (s, 6H, 18, 18'-Me), 1.79 (ddd,2H, J = 1.7 Hz, J = 3.3 Hz, J = 12.1 Hz, H-2eq, H-2'eq), 1.97, 1.98, 1.99 (3s, 14H, 19, 19', 20, 20'-Me, 2 HC?C), 2.13 (dd, 2H, J = 9.4 Hz, J = 16.9 Hz, H-4ax, H-4'ax), 2.44 (dd, 2H, J = 5.7 Hz, J = 17.1 Hz, H-4eq, H-4'eq), 2.49-2.57 (m, 8H, 4 CH2 pentynoate), 5.07-5.13 (m, 2H, H-3, H-3'), 6.07-6.12 (m, 4H, H-7, 7', 8, 8'), 6.16 (d, 2H, J = 11.7 Hz, H-10, 10'), 6.26 (d, 2H, J = 9.7 Hz, H-14, 14'), 6.37 (d, 2H, J = 14.9 Hz, H-12, 12'), 6.61-6.67 (m, 4H, H-11, 11', 15, 15'). 13C NMR (125 MHz, CDCl3): delta 12.7, 12.8 (19, 19', 20, 20'-Me), 14.4 (2 CH2-C?C), 21.5 (18, 18'-Me), 28.5, 30.0 (16, 16', 17, 17'-Me), 33.7 (2 CH2-CO), 36.7, 38.4, 44.0 (C-1, 1', 2, 2', 4, 4'), 68.9 (C-3, 3'), 69.0 (2 C?CH), 82.6 (2 C?CH), 124.9 (C-11, 11'), 125.2 (C-7, 7'), 125.5 (C-5, 5'), 130.1, 131.5, 132.6 (C-10, 10', 14, 14', 15, 15'), 136.5 (C-9, 9'), 137.7 (C-13, 13'), 137.7 (C-12, 12'), 137.9 (C-6, 6'), 138.7 (C-8, 8'), 171.4 (2 C=O). MS (MALDI-TOF, positive mode, with DHB matrix) m/z 728.3 (M+). Anal. Calcd. for C50H64O4: C 82.37, H 8.85, found C 82.32, H8.47. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | To a stirred solution of (pent-4-ynoic acid ( 1 g, 10.19 mmol) in N,N- dimethylformamide (10 ml), EDC (2. 150 g, 1 1.21 mmol), HOBT ( 1.717 g, 1 1.21 mmol) were added and the reaction mixture was stirred for 30 minutes. After 30 minutes 4-(piperazin- l-yl)benzonitrile (2.100 g, 1 1.21 mmol) was added followed by diisopropylethylamine (3.74 ml, 21.41 mmol) and the reaction mixture was stirred at 25 C for 18 h. The progress of the reaction was monitored by TLC. The reaction mixture was concentrated under reduced pressure and residue was diluted with water (50 ml) and extracted with ethyl acetate (2 x 50 ml). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain a crude product which was purified by flash column chromatography over silica gel (200 - 400 mesh) using 70% ethyl acetate in hexane to obtain the title compound (2.2 g, 81% yield). iH NMR (400 MHz, CDC13): delta 7.60 - 7.49 (m, 2H), 6.97 - 6.86 (m, 2H), 3.82 (t, J = 5.4 Hz, 2H), 3.68 (dd, J = 6.8, 3.8 Hz, 2H), 3.43 - 3.31 (m, 4H), 2.83 (s, 1H), 2.70 - 2.52 (m, 4H). MS: m/z 268.1 (M+ l) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
DGEA-alkyne peptide 14 was synthesized manually using standard solid-phase Fmoc protocols with Fmoc-amino acids and 4-pentynoic acid and was prepared as a C-terminal amide using Rink amide MBHA resin. Each acylation with Fmoc-amino acids or 4-pentynoic acid was performed using HATU (4 equiv) and N,N-diisopropylethylamine (DIPEA) (4 equiv) for 45 minutes in dimethylformamide (DMF) at room temperature, followed by Fmoc deprotection with 20% piperidine in DMF. DMF was used to wash the resin between each acylation and deprotection step. Cleavage from the resin was conducted by treatment with a mixture of 95% trifluoroacetic acid, 2.5% water, and 2.5% triisopropylsilane (TIPS) at room temperature for 2 hours. The peptide was purified by reverse-phase HPLC and characterized by ESI-MS. HPLC Purification: Reverse-phase HPLC purification of 14 was performed on a Shimadzu CBM-20A instrument with Phenomenex Jupiter 4t Proteo 90A (250 x 15 mm preparative) and Phenomenex Jupiter 4t Proteo 90A (250 x 4.6 mm analytical) columns. The columns were eluted with a gradient of acetonitrile in water (10-60%) (flow rates of 8 mL/min and 1 mL/min for preparativeand analytical columns, respectively). Trifluoroacetic acid (0.1%) was added to all eluents. The formed structure is illustrated herein as Scheme 4. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In chloroform; | Example B125 4-Pentynamide 1-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (6775 mg) and <strong>[1066-33-7]ammonium hydrogencarbonate</strong> (5905 mg) were added to a solution of 4-pentynoic acid (2446 mg) in chloroform (75 ml), and this reaction mixture was stirred at room temperature for 17.5 hours. The reaction mixture was filtered through celite and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (249 mg). 1H-NMR(DMSO-d6) delta (ppm):2.21(2H, t), 2.29-2.33(2H, m), 2.73(1H, t), 6.78-6.88(1H, m), 7.28-7.38(1H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Amino acid extensions onto the pre-loaded (psi-R35, Y36)-Sieber resin from Example 1, step 2 (0.1 mmol) were carried out at rt using NMP as solvent, a 5-fold excess of protected amino acids and an HATU/DIEA protocol (1 h, single coupling); Fmoc-Arg(pbf)-OH and Fmoc-His(trt)-OH were double coupled. A two-stage Fmoc deprotection protocol was used throughout (20% piperidine in DMF; rt; 10 min, 15 min). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1. Synthesis of H2N-IKPEAPGEDASPEELNRYYASLRHYLNL(hC) TRQRY-PAL-PEG Resin (0402) The protected peptidyl resin was synthesized using Fmoc strategy as described above on a CEM Liberty Blue Microwave peptide synthesizer using low loading Rink amide resins, preferably, Fmoc-PAL-PEG PS resin (ca., 0.16-0.2 meq/g, supplied by Applied Biosystems) on a scale of 0.1 mmol, as depicted in Scheme 1. Standard Fmoc-protected amino acids were coupled in 5-fold excess relative to resin loading using DIC/Oxyma as the coupling agents and a reaction temperature of ca., 90 C. for 4 min. Fmoc-Arg(Pbf)-OH was double coupled at 90 C. for 4 min each and Fmoc-His(Trt)-OH was coupled using a two-stage protocol: 4 min at rt followed by 8 min at 50 C. Single Fmoc deprotections were carried out using 20% piperidine in DMF (deprotection solution) at 90 C. for 1.5 min. 2. Synthesis of m-BrCH2PhCOHN-IKPEAPGEDASPEELNRYYASLRHYLNL(hC) TRQRY-PAL-PEG Resin (0403) The Fmoc-deprotected peptide-resin (0.1 mmol) from above was treated with a solution of m-bromomethylbenzoic acid (20 eq.) and DIC (10 eq.) in DMF (4 mL) in a microwave reactor at 75 C. for 15 min, by which time the reaction was generally determined to be complete, as per a Kaiser ninhydrin test (Kaiser, et al., Anal. Biochem., 1970, 34, 595-598). In cases where the coupling was determined to be incomplete, the coupling was repeated with fresh reagents. The reaction was drained, and the resin was washed extensively with DMF and DCM. 3. Synthesis of m-BrCH2PhCOHN-IKPEAPGEDASPEELNRYYASLRHYLNL(hC) TRQRY-CONH2: Deprotection and Cleavage from Resin The resin from above was then treated with a cleavage cocktail (10 mL/0.1 mmol scale) consisting of TFA/water/phenol/TIPS (88:5:5:2) and heated in a microwave reactor at 38 C. for 40 min, then filtered. The resin was washed with TFA and the combined filtrates were concentrated under a stream of nitrogen to a volume of ca. 2.5 mL and the peptide was precipitated by the addition of cold diethyl ether (40 mL). The peptide/ether suspension was centrifuged and the ether layer was decanted. The peptide pellet was re-suspended in ether, centrifuged and decanted, and this process was repeated a third time. The crude peptide thus obtained was dried under a mild nitrogen stream. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1. Synthesis of (HCCH(CH2)2CONH)-IKPEAPGEDASPEELNRYYASLRHYLNK(Dde)-(azido-norLeu)-TRQRY-PAL-PEG Resin The resin-bound peptide was prepared as described in Example 3, step 1, substituting Fmoc-Lys(Dde)-OH in place of Fmoc-Leu-OH at position 30 and incorporating the 4-pentynoic acid (double coupled) in this step at position 2, following Fmoc-Ile-OH at position 3. 2. Synthesis of (HCCH(CH2)2CONH)-IKPEAPGEDASPEELNRYYASLRHYLNK(NH2)-(azido-norLeu)-TRQRY-PAL-PEG Resin The above resin was treated with 3% hydrazine in DMF (8 mL/0.1 mmol scale) for 5 min at rt and then the mixture was drained and washed with DMF. This procedure was repeated ca. 5×, after which the resin was washed extensively with DMF and then DCM. 3. Synthesis of (HCCH(CH2)2CONH)-IKPEAPGEDASPEELNRYYASLRHYLNK(NH-gamma-Glu-AcVitE)-(azido-norLeu)-TRQRY-PAL-PEG Resin Fmoc-Glu-OtBu was coupled onto the above resin using the coupling protocol described in Example 2, step 1 with a 5 min coupling time. The resin was deprotected by treatment with 20% piperidine in DMF using a 3-stage microwave protocol (75 C., 0.5 min; 75 C., 3 min; 75 C., 3 min), after which the resin was washed extensively with DMF and DCM. alpha-Tocopheryloxyacetic Acid (AcVitE) (8) was then coupled onto the resin using the same procedure used for coupling Fmoc-Glu-OtBu. 4. Synthesis of (HCCH(CH2)2CONH)-IKPEAPGEDASPEELNRYYASLRHYLNK(NH-gamma-Glu-AcVitE)-(azido-norLeu)-TRQRY-CONH2 Cleavage and precipitation of the peptide from the above resin was carried out using the procedure described in Example 3, step 3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: Peptide synthesis was based on Fmoc chemistry, using a Symphony peptide synthesiser manufactured by Peptide Instruments and a Syro II synthesiser by MultiSynTech. Standard Fmoc- amino acids were employed (Sigma, Merck), with the following side chain protecting groups: Arg(Pbf); Asn(Trt); Asp(OtBu); Cys(Trt); GIu(OtBu); Gln(Trt); His(Trt); Lys(Boc); Ser(tBu); Thr(tBu); Trp(Boc); and Tyr(tBu) (Sigma). The coupling reagent was HCTU (Pepceuticals), diisopropylethylamine (DIPEA, Sigma) was employed as a base, and deprotection was achieved with 20percent piperidine in DMF (AGTC). Syntheses were performed using 0.37 mmol/gr Fmoc-Rink amide AM resin (AGTC), Fmoc-amino acids were utilised at a four-fold excess, and base was at a four-fold excess with respect to the amino acids. Amino acids were dissolved at 0.2M in DMSO, HCTU at 0.4M in DMF, and DIPEA at 1.6M in N-methylpyrrolidone (Alfa Aesar). Conditions were such that coupling reactions contained between 20 to 50percent DMSO in DMF, which reduced aggregation and deletions during the solid phase synthesis and enhanced yields. Coupling times were generally 30 minutes, and deprotection times 2 x 5 minutes. Fmoc-N-methylglycine (Fmoc- Sar-OH, Merck) was coupled for 1 hr, and deprotection and coupling times for the following residue were 20 min and 1 hr, respectively. After synthesis, the resin was washed with dichloromethane, and dried. Cleavage of side-chain protecting groups and from the support was effected using 10 mL of 95:2.5:2.5:2.5 v/v/v/w TFA/H20/iPr3SiH/dithiothreitol for 3 hours. Following cleavage, the spent resin was removed by filtration, and the filtrate was added to 35 mL of diethylether that had been cooled at -80°C. Peptide pellet was centrifuged, the etheric supernatant discarded, and the peptide pellet washed with cold ether two more times. Peptides were then resolubilised in 5-10 mL acetonitrile-water and lyophilised. A small sample was removed for analysis of purity of the crude product by mass spectrometry (MALDI-TOF, Voyager DE from Applied Biosystems). Following lyophilisation, peptide powders were taken up in 10 mL 6 M guanidinium hydrochloride in H20, supplemented with 0.5 mL of 1 M dithiothreitol, and loaded onto a C8 Luna preparative HPLC column (Phenomenex). Solvents (H20, acetonitrile) were acidified with 0.1 percent heptafluorobutyric acid. The gradient ranged from 30-70 percent acetonitrile in 15 minutes, at a flowrate of 15-20 mL /min, using a Gilson preparative HPLC system. Fractions containing pure linear peptide material (as identified by MALDI) were used for preparation of the bicycle derivatives by coupling to a scaffold molecule as described further below.A bicycle peptide designated 17-69-07-N434 was made corresponding to the bicycle peptide of Example lwith an N-terminal SarlO spacer similar to that of Reference Example 1, and conjugating group PYA (4-pentynoic acid, for "click" derivatisation with toxin). The structure of this derivative is shown schematically in Fig. 5. The linear peptide used to form this bicycle was as follows:(PYA)-(B-Ala)-SarlO-A(Dap)(D-Ala)NE(lNal)(D-Ala)CEDFYD(tBuGly)(Dap)The linear peptide and the bicycle peptide had the following LCMS Characteristics: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.48 g | To a magnetically stirred solution of S-I-V (0.26 g) in MeOH (30 mL) was added N-cyclohexyl- 1,3 -prop anediamine (0.54 g). After the mixture was stirred at 25for 1 h, NaBH4 (0.24 g) was added to the mixture slowly. The resulting mixture was stirred for another 15 h and then quenched with NH4C1(aq) (50 mL, 2M). The mixture was concentrated. The residue was extracted with CH2C12 (2x150 mL). The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, and filtered. To a magnetically stirred filtrate was added Boc2O anhydride (0.84 g) in one potion. The mixture was stirred at room temperature for 15 h and then concentrated. The residue was purified by flash column chromatography over silica gel with n-hexane/ethyl acetate (2:1) to afford the product 5-1-VI (0.48 g, y: 36% oversteps). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | General procedure: A suspension of alkynoic acids 1 (0.6 mmol), amine nucleophiles 2 or 3 (0.5 mmol), andAuPPh3Cl/AgSbF6 (with the amount indicated) in H2O (4.0 mL) was stirred at the temperatureindicated for 20 h. Then the reaction mixture was cooled to room temperature, and CF3COOH(0.5 mmol) was added, and the resulting mixture was stirred for another 4 h at the temperatureindicated. At ambient temperature, saturated Na2CO3 solution (25.0 mL) was added to the reactionmixture. The resulting mixture was then extracted with ethyl acetate (3 15 mL). The combinedorganic layers were washed with brine, and dried over Na2SO4. After filtration and removal of thesolvents in vacuo, the crude product was purified by flash chromatography on silica gel to yield thedesired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | Stage #1: [2-(2-thyenyl)ethyl]amine; 4-pentynoic acid With (triphenylphosphine)gold(I) chloride In 1,2-dichloro-ethane at 140℃; for 20h; Sealed tube; Stage #2: With trifluoroacetic acid In 1,2-dichloro-ethane at 140℃; for 4h; regioselective reaction; | |
63% | Stage #1: [2-(2-thyenyl)ethyl]amine; 4-pentynoic acid With silver hexafluoroantimonate; (triphenylphosphine)gold(I) chloride In water at 140℃; for 20h; Green chemistry; Stage #2: With trifluoroacetic acid In water at 140℃; for 4h; Green chemistry; | 3.3. General Procedure for the Preparation of Compounds SF1c, SF2-SF4, SF5d, SF5e and SF6-SF46 General procedure: A suspension of alkynoic acids 1 (0.6 mmol), amine nucleophiles 2 or 3 (0.5 mmol), andAuPPh3Cl/AgSbF6 (with the amount indicated) in H2O (4.0 mL) was stirred at the temperatureindicated for 20 h. Then the reaction mixture was cooled to room temperature, and CF3COOH(0.5 mmol) was added, and the resulting mixture was stirred for another 4 h at the temperatureindicated. At ambient temperature, saturated Na2CO3 solution (25.0 mL) was added to the reactionmixture. The resulting mixture was then extracted with ethyl acetate (3 15 mL). The combinedorganic layers were washed with brine, and dried over Na2SO4. After filtration and removal of thesolvents in vacuo, the crude product was purified by flash chromatography on silica gel to yield thedesired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere; | 26 Preparation of Compound K-i To a solution of L-Lys(Boc)-OMe (3 g, i 0. ii mmol) and 4-pentynoic acid (992 mg,iO.i i mmol) in DIVIF (30 mL) was added in one portion PyBop (7.89 g, i5.i6 mmol) followedby DIPEA (5.26 mL, 30.32 mmol) at 0°C under N2 atmosphere. The mixture was stirred overnight at room temperature. EA (80 mL X 4) and saturated citric acid (60 mL) were added to the mixture and organic layer was washed with NaHCO3 (120 mL), brine (100 mL), dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column chromatography to obtain compound K-i (3.29 g, 95 %).El-MS m/z: 341 (M). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Peptide 3 was synthesized using standard automated flow chemistry using 200 mg of resin except ferf-buty thiol protected cysteine was incorporated for cysteine residues 1 and 3 and trityl protected cysteine was mcorporated for cysteme residues 2 and 4, The terl-huiy] thiol groups were deprotected on resin using 3.8 mmol DTT in 2.5 mL DMF with 0.25 mL DIEA. The reaction proceeded at 60 C for 20 minutes. The resin was washed 3 times with DMF, followed by the addition of decafiuorobiphenyl (1 mmol) with 2.5 mL DMF and 0.25 mL DIEA. The reaction proceeded at room temperature for 2 hours, and then the resin was washed with DMF (3x) and DCM (3x). The peptide was then cleaved from the resin and purified as normal to afford 3a. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Peptide 6 was synthesized using standard automated flow chemistry using 200 mg of resin except ferf-butyl thiol protected cysteine was incorporated for cysteine residue 1 and trityl protected cysteine was incorporated for cysteine residue 2. The tert-butyl groups were deprotected on resin using 3.8 mmol DTT in 2,5 mL DMF with 0.25 mL DIEA. The reaction proceeded at 60 C for 20 minutes. The resin was washed 3x with DMF, followed by the addition of decafluorobiphenyl (1 mmol) with 2.5 mL DMF and 0.25 mL DIEA. T e reaction proceeded at room temperature for 2 hours, and then the resin was washed with DMF (3x) and DCM (3x). The peptide was then cleaved from the resin and purified as normal to afford the monoaryl 6a. (0334) Peptide 6a was macrocyclized by suspending the peptide (12 mg, 3.9 muetaiotaomicron, assuming 6 coordinated TFA salts) was suspended in 3.9 mL DMF. Neat DIEA (33.8 mu?) was added to achieve a concentration of 50 mM. The reaction was allowed to proceed for 5 minutes, after which complete conversion was observed. DMF was removed by rotary evaporation to a final volume of 1 mL and the reaction was quenched by adding 39 mL of water containing 2% TFA, The reaction was purified by mass-directed semi-preparative reversed-phase FIPLC to provide peptide 6c (8.4 mg, 88% yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Peptide 3 was synthesized using standard automated flow chemistry except rr-butyl thiol protected cysteine was mcorporated for cysteine residues and 2 and trityl protected cysteine was incorporated for cysteine residues 3 and 4. After cleavage and deprotection, the peptide was purified by reversed-phase HPLC, The peptide was macrocyclized using a procedure analogous to Example 3. ter^butylthiol protected cysteine residues 1 and 2 were deprotected by incubating the peptide (1 mM) with DTT (50 mM) and Tris (25 mM pH 8) in water. After solid-phase extraction (SPE) to remove residual DTT, the remaining two free cysteine residues were macrocyclized using a procedure analogous to Example 3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | With dmap; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In N,N-dimethyl-formamide; at 20℃; for 24h; | A 25 mL round bottom flask was charged with 193 mg of Ibrutinib intermediate (cas: 1022150-12-4), 3 mL of anhydrous DMF, 75 mg of HOBT, 106 mg of EDCI, 49 mg of pentynyl acid, 77 muL of triethylamine, and 10 mg of DMAP.The reaction solution was stirred at room temperature for 24 hours.15 mL of saturated sodium chloride aqueous solution was added to quench the reaction, the mixture was extracted three times with 15 mL × 3 ethyl acetate, and the organic phases were combined,It was dried over anhydrous sodium sulfate, and the solvent was spin-dried. A 200-300 mesh silica gel column was used for separation and purification. The mobile phase was dichloromethane: methanol = 40: 1, and intermediate 1c was obtained with a yield of 61%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 48h; | 2.2 2.3 Synthesis of bis-alkyne ethyl disulfide crosslinker (disulfanediylbis(ethane-2,1-diyl) bis(pent-4-ynoate) Disulfanediylbis(ethane-2,1-diyl) bis(pent-4-ynoate) was synthesised by adding 1.31 g (8.49 mmol) of 2-hydroxyethyl disulfide, 3.90 g (20.34 mmol) of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDAC), and 4-pentynoic acid (2 g, 20.38 mmol) into a flask containing anhydrous dichloromethane at 0°C. Afterwards, 4-(dimethylamino) pyridine (0.25 g, 2.05 mmol) was dissolved in dichloromethane and then was added under stirring and the mixture was left to react for 48 h at room temperature. The purification of the bis-alkyne crosslinker was carried out by washing the reaction product with the followed solutions: 1M hydrochloric acid (3×100mL), 1 M sodium hydroxide (3×100mL) and 1M NaCl (200mL). The mixture was then dried over MgSO4 and the solvent was removed under reduced pressure. Finally, the crude product was purified by flash column chromatography (hexane: ethyl acetate 4:3) yielding 0.98g, (75%). 1H NMR (400MHz, CDCl3, δ in ppm): 4.39 (t, 4H), 2.95 (t, 4H), 2.63-2.57 (m, 4H), 2.56-2.50 (m, 4H), 2.01 (t, 2H). The characterisation data were in accord with prior literature reports for this compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | In methanol; at 20℃; | General procedure: A solution of the corresponding aldehyde (1 mmol),isocyanide (1 mmol), and carboxylic acid (1 mmol) inmethanol MeOH (2 mL) was kept at room temperaturefor 2-6 days (TLC monitoring). After completion ofthe reaction, the solvent was removed on a rotaryevaporator, and the residue (compound 3a-3n) was purifiedby column chromatography using hexane-ethylacetate or methylene chloride-methanol as eluent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 1h; | A mixture of palbociclib (224 mg, 0.5 mmol) and but-3-ynoic acid (50 mg, 0.5 mmol) in DMF (10 ml) was treated with DIPEA (166 pL, 1.0 mmol) and then HATU (190 mg, 0.5 mmol) and stirred at ambient temperature for 1 hour. After which time the reaction mixture was diluted with H20 and extracted with EtOAc. The organic layer was dried by Na2S04and concentrated in vacuum. The resulting material was purified by chromatography on silica to afford palbociclib-alkyne YX-2-76 (185 mg, 70% yield). LC-MS RT = 1.43, ES+ve 528. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; triethylamine; In 1,2-dimethoxyethane; for 12.0h;Inert atmosphere; Reflux; | Under the protection of nitrogen, compound S66 (166 mg, 0.45 mmol), compound S72 (44 mg, 0.45 mmol),PdCl2(PPh3)2 (16mg, 0.02mmol), cuprous iodide (4mg, 0.02mmol) were added to 10mL of DME in turn,After stirring to dissolve, triethylamine (182 mg, 1.8 mmol) was added, and the reaction was refluxed for 12 hours. Reaction complete, Add 10 mL of water to the system, extract with ethyl acetate, combine the organic phases, and wash with saturated brine,Dry with anhydrous sodium sulfate, filter, collect the filtrate and concentrate to obtain a crude product. The crude product was separated and purified by silica gel column chromatography to obtain white solid compound S73 (68 mg, 45% yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; N-[3-(N,N-dimethylamino)-propyl]-N'-ethyl-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 24h; Inert atmosphere; | 3; 104; 107-119 The method of preparation of capsaicin derivatives shown in Formula II-1 above, comprising the following steps: In the reaction vessel were added 5-(aminomethyl)-2-methoxyphenol hydrochloride, alkali, 1- (3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole, alkyne acid and organic solvent, reacted at 20 °C for 24 hours to obtain the reaction liquid, to be cooled to room temperature, vacuum concentration, residue over 200 mesh silicone column chromatography to give the capsaicin derivative shown in formula II-1, wherein: Silica gel column chromatography uses a mixture of petroleum ether and ethyl acetate in a volume ratio of 3:1 as the eluent; The molar ratio of 5-(aminomethyl)-2-methoxyphenol hydrochloride, base, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole, alkyne acid, organic solvent is 1:4:1.5:1.5:1:1:40. Further, the base is N,N- diisopropylethylamine. Further, the organic solvent is acetonitrile. |
Tags: 6089-09-4 synthesis path| 6089-09-4 SDS| 6089-09-4 COA| 6089-09-4 purity| 6089-09-4 application| 6089-09-4 NMR| 6089-09-4 COA| 6089-09-4 structure
[ 933755-97-6 ]
1-Ethynylcyclopropanecarboxylic acid
Similarity: 0.73
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :